ArticleJournal of clinical medicine2025

Pre-Procedural Use of Levosimendan in High-Risk ACS-PCI Patients with Reduced Left Ventricle Ejection Fraction-Short-Term Outcomes.

Karol Turkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.